---
title: "NAVIDEA BIOPHARMACEUTICALS INC S-1"
date: 2022-02-15T23:17:47
image: "NAVIDEABIOPHARMACEUTICALSINC_S-1_20220215-231747.png"
companies: "NAVIDEA BIOPHARMACEUTICALS INC"
industry: "IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
tags: ["NAVIDEA BIOPHARMACEUTICALS INC","IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES","02-14-2022","S-1"]
forms: "S-1"
---
NAVIDEA BIOPHARMACEUTICALS INC, which is in the In Vitro & In Vivo Diagnostic Substances [2835] industry, SEC S-1 filing on February 14, 2022 had 23116 (cleaned) words - 600 were utilized for the visualizations.

Top Words:
1. subscription - 493 instances
2. rights - 474 instances
3. stock - 421 instances
4. offering - 292 instances
5. shares - 289 instances


See the parsed data used in the visualization [here]({{< staticlink name=NAVIDEABIOPHARMACEUTICALSINC_S-1_20220215-231747.json >}}).  
View the actual filing on the SEC website [here](https://www.sec.gov/Archives/edgar/data/810509/0001437749-22-003169.txt)